You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金河生物(002688.SZ):子公司參與開發的豬偽狂犬病滅活疫苗(gE/TK基因缺失HD/c株)獲得新獸藥註冊證書
格隆匯 02-27 17:19

格隆匯2月27日丨金河生物(002688.SZ)公佈,根據國家《獸藥管理條例》和《獸藥註冊辦法》規定,經農業農村部審查,批准金河生物科技股份有限公司子公司杭州佑本動物疫苗有限公司(簡稱“杭州佑本”)與浙江大學、成都史紀生物製藥有限公司聯合開發的豬偽狂犬病滅活疫苗(gE/TK基因缺失HD/c株)為新獸藥,核發了《新獸藥註冊證書》。該藥品用於預防豬偽狂犬病毒感染引起的疾病,免疫產生期為免疫後21日,免疫持續期為4個月。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account